{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:23:58Z","timestamp":1779189838640,"version":"3.51.4"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.clim.2009.04.009","type":"journal-article","created":{"date-parts":[[2009,5,30]],"date-time":"2009-05-30T09:28:50Z","timestamp":1243675730000},"page":"171-178","source":"Crossref","is-referenced-by-count":70,"title":["Haploidentical hemopoietic stem cell transplantation for the treatment of high-risk leukemias: How NK cells make the difference"],"prefix":"10.1016","volume":"133","author":[{"given":"Franco","family":"Locatelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Pende","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rita","family":"Maccario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Cristina","family":"Mingari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Moretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Moretta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2009.04.009_bib1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1056\/NEJMra052603","article-title":"Treatment of acute lymphoblastic leukaemia","volume":"354","author":"Pui","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2009.04.009_bib2","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1182\/blood-2006-06-027714","article-title":"Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukaemia","volume":"109","author":"Moghrabi","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clim.2009.04.009_bib3","doi-asserted-by":"crossref","first-page":"4477","DOI":"10.1182\/blood-2007-09-112920","article-title":"Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95","volume":"111","author":"Moricke","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clim.2009.04.009_bib4","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1038\/sj.leu.2401963","article-title":"Long-term results of the Italian Association of Pediatric Hematology and Oncology (AIEOP) Acute Lymphoblastic Leukemia Studies, 1982\u20131995","volume":"14","author":"Conter","year":"2000","journal-title":"Leukemia"},{"issue":"23","key":"10.1016\/j.clim.2009.04.009_bib5","doi-asserted-by":"crossref","first-page":"7161","DOI":"10.1200\/JCO.2005.11.411","article-title":"for: Associazione Italiana di Ematologia Oncologia Pediatrica (AIEOP); Dutch Childhood Oncology Group (DCOG); Hungarian Pediatric Hematology Oncology Group (HPOG). Long term results of a randomized trial on extended use of high dose l-asparaginase for standard risk childhood acute lymphoblastic leukemia","volume":"23","author":"Pession","year":"2005","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.clim.2009.04.009_bib6","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1182\/blood.V78.5.1166.bloodjournal7851166","article-title":"Six-year experience with a comprehensive approach to the treatment of recurrent childhood acute lymphoblastic leukemia (ALL-REZ BFM 85): a relapse study of the BFM group","volume":"78","author":"Henze","year":"1991","journal-title":"Blood"},{"key":"10.1016\/j.clim.2009.04.009_bib7","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/leu.2008.227","article-title":"Minimal residual disease is an important predictive factor of outcome in children with relapsed \u201chigh-risk\u201d acute lymphoblastic leukemia","volume":"22","author":"Paganin","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.clim.2009.04.009_bib8","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1365-2141.2003.04584.x","article-title":"Long-term follow-up of relapsed childhood acute lymphoblastic leukaemia","volume":"123","author":"Chessells","year":"2003","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clim.2009.04.009_bib9","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.clim.2009.04.009_bib10","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/S0140-6736(68)92673-1","article-title":"Immunological reconstitution of sex linked lymphopenic immunological deficiency","volume":"2","author":"Gatti","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2009.04.009_bib11","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S0140-6736(68)92672-X","article-title":"Bone marrow transplantation in a patient with the Wiskott\u2013Aldrich syndrome","volume":"2","author":"Bach","year":"1968","journal-title":"Lancet"},{"key":"10.1016\/j.clim.2009.04.009_bib12","doi-asserted-by":"crossref","first-page":"4233","DOI":"10.1182\/blood-2002-08-2510","article-title":"Unrelated donor hematopoietic cell transplantation: marrow or umbilical cord blood?","volume":"101","author":"Grewal","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clim.2009.04.009_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/sj.bmt.1705963","article-title":"Searching for alternative hematopoietic stem cell donors for pediatric patients","volume":"41","author":"Rocha","year":"2008","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.clim.2009.04.009_bib14","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1038\/nm1295-1268","article-title":"Megadose of T cell-depleted bone marrow overcomes MHC barriers in sublethally irradiated mice","volume":"1","author":"Bachar-Lustig","year":"1995","journal-title":"Nat. Med."},{"key":"10.1016\/j.clim.2009.04.009_bib15","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1056\/NEJM199810223391702","article-title":"Treatment of high risk acute leukaemia with T-depleted stem cells from related donors with one fully mismatched HLA haplotype","volume":"339","author":"Aversa","year":"1998","journal-title":"N. Eng. J. Med."},{"key":"10.1016\/j.clim.2009.04.009_bib16","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2005.09.117","article-title":"Full haplotype-mismatched hematopoietic stem-cell transplantation: a phase II study in patients with acute leukemia at high risk of relapse","volume":"23","author":"Aversa","year":"2005","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.clim.2009.04.009_bib17","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1126\/science.1068440","article-title":"Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants","volume":"295","author":"Ruggeri","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.clim.2009.04.009_bib18","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bcmd.2004.08.017","article-title":"Long-term outcome after haploidentical stem cell transplantation in children blood","volume":"33","author":"Lang","year":"2004","journal-title":"Cell Mol. Dis."},{"key":"10.1016\/j.clim.2009.04.009_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/j.1365-2141.2006.06140.x","article-title":"Haploidentical stem cell transplantation for children with acute leukaemia","volume":"134","author":"Marks","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clim.2009.04.009_bib20","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1182\/blood-2008-01-135285","article-title":"Survival after T cell-depleted haploidentical stem cell transplantation is improved using the mother as donor","volume":"112","author":"Stern","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clim.2009.04.009_bib21","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1038\/sj.bmt.1704842","article-title":"Graft dysfunction and delayed immune reconstitution following haploidentical peripheral blood hematopoietic stem cell transplantation","volume":"35","author":"Ball","year":"2005","journal-title":"Bone Marrow Transplant."},{"key":"10.1016\/j.clim.2009.04.009_bib22","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1086\/597123","article-title":"Human cytomegalovirus-specific T cell reconstitution in young patients receiving T cell-depleted, allogeneic hematopoietic stem cell transplantation","volume":"199","author":"Lilleri","year":"2009","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.clim.2009.04.009_bib23","doi-asserted-by":"crossref","first-page":"4397","DOI":"10.1182\/blood-2005-05-1775","article-title":"Transferring functional immune responses to pathogens after haploidentical hematopoietic transplantation","volume":"106","author":"Perruccio","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clim.2009.04.009_bib24","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1111\/j.1600-6143.2007.01823.x","article-title":"Preemptive treatment of EBV-related post-transplant lymphoproliferative disorders after pediatric haploidentical stem cell transplantation","volume":"7","author":"Comoli","year":"2007","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.clim.2009.04.009_bib25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2141.2006.06108.x","article-title":"Safe adoptive transfer of virus-specific T-cell immunity for the treatment of systemic adenovirus infection after allogeneic stem cell transplantation","volume":"134","author":"Feuchtinger","year":"2006","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.clim.2009.04.009_bib26","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2007-04-087056","article-title":"Cotransplantation of ex vivo expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation","volume":"110","author":"Ball","year":"2007","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.clim.2009.04.009_bib27","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1182\/blood-2005-07-2775","article-title":"Mesenchymal stem cell (MSC)\/natural killer (NK) cell interactions: evidence that activated NK cells are capable of killing MSC while MSC can inhibit IL-2-induced NK cell proliferation","volume":"107","author":"Spaggiari","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.clim.2009.04.009_bib28","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1182\/blood-2007-02-074997","article-title":"Mesenchymal stem cells inhibit natural killer cell proliferation, cytotoxicity and cytokine production: role of indoleamine 2,3-dioxygenase and prostaglandin E2","volume":"111","author":"Spaggiari","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.clim.2009.04.009_bib29","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(90)90097-S","article-title":"In search of the \u201cmissing self\u201d. MHC molecules and NK cell recognition","volume":"11","author":"Ljunggren","year":"1990","journal-title":"Immunol. Today"},{"key":"10.1016\/j.clim.2009.04.009_bib30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0065-2776(08)60034-6","article-title":"Biology and genetics of hybrid resistance","volume":"41","author":"Bennet","year":"1987","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.clim.2009.04.009_bib31","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1084\/jem.171.3.695","article-title":"A novel surface antigen expressed by a subset of human CD3-CD16+ natural killer cells. Role in cell activation and regulation of cytolytic function","volume":"171","author":"Moretta","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2009.04.009_bib32","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1084\/jem.172.6.1589","article-title":"Identification of four subset of human CD3-CD16+ NK cells by the expression of clonally distributed functional surface molecules. Correlation between subset assignment of NK clones and ability to mediate specific alloantigen recognition","volume":"172","author":"Moretta","year":"1990","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2009.04.009_bib33","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1084\/jem.178.2.597","article-title":"p58 molecules as putative receptors for MHC class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities","volume":"178","author":"Moretta","year":"1993","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2009.04.009_bib34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/1074-7613(95)90025-X","article-title":"Molecular clones of the p58 natural killer cell receptor reveal Ig-related molecules with diversity in both the extra- and intracellular domains","volume":"2","author":"Wagtmann","year":"1995","journal-title":"Immunity"},{"key":"10.1016\/j.clim.2009.04.009_bib35","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1126\/science.7716543","article-title":"Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells","volume":"268","author":"Colonna","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.clim.2009.04.009_bib36","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1084\/jem.180.2.537","article-title":"NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules","volume":"180","author":"Litwin","year":"1994","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2009.04.009_bib37","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1073\/pnas.93.4.1453","article-title":"Physical and functional independency of p70 and p58 NK cell receptors for HLA-class I. Their role in the definition of different groups of alloreactive NK cell clones","volume":"93","author":"Vitale","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.clim.2009.04.009_bib38","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1084\/jem.184.2.505","article-title":"The Natural Killer cell receptor specific for HLA.A allotypes: a novel member of the p58\/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140\u00a0kD disulphide-linked dimer","volume":"184","author":"Pende","year":"1996","journal-title":"J. Exp. Med."},{"issue":"2","key":"10.1016\/j.clim.2009.04.009_bib39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1002\/eji.1830260215","article-title":"Human natural killer cell inhibitory receptors bind to HLA class I molecules","volume":"26","author":"Dohring","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2009.04.009_bib40","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1084\/jem.182.3.875","article-title":"Existence of both inhibitory (p58) and activatory (p50) receptors for HLA.C molecules in human natural killer cells","volume":"182","author":"Moretta","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2009.04.009_bib41","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1084\/jem.183.2.645","article-title":"The HLA.C specific \u201cactivatory\u201d and \u201cinhibitory\u201d natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions","volume":"183","author":"Biassoni","year":"1996","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2009.04.009_bib42","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1002\/eji.1830260823","article-title":"A novel surface molecule homologous to the p58\/p50 family of receptors is selectively expressed on a subset of human natural killer cells and induces both triggering of cell functions and proliferation","volume":"26","author":"Bottino","year":"1996","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2009.04.009_bib43","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1146\/annurev.immunol.14.1.619","article-title":"Receptors for HLA-class I molecules in human natural killer cells","volume":"14","author":"Moretta","year":"1996","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2009.04.009_bib44","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/ni0102-6","article-title":"What is a natural killer cell?","volume":"3","author":"Moretta","year":"2002","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2009.04.009_bib45","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1146\/annurev.immunol.16.1.359","article-title":"NK cell receptors","volume":"16","author":"Lanier","year":"1998","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2009.04.009_bib46","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1146\/annurev.immunol.17.1.875","article-title":"Regulation of immune responses through inhibitory receptors","volume":"17","author":"Long","year":"1999","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.clim.2009.04.009_bib47","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1006\/smim.2000.0213","article-title":"NK cell recognition of non-classical HLA class I molecules","volume":"12","author":"Lopez-Botet","year":"2000","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.clim.2009.04.009_bib48","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1093\/intimm\/7.4.697","article-title":"Cytolytic T lymphocytes displaying natural killer (NK)-like activity. Expression of NK-related functional receptors fir HLA-class I molecules (p58 and CD94) and inhibitory effect on the TCR-mediated target cell lysis or lymphokine production","volume":"7","author":"Mingari","year":"1995","journal-title":"Int. Immunol."},{"key":"10.1016\/j.clim.2009.04.009_bib49","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S1471-4906(03)00031-0","article-title":"NK-CTL, a novel HLA-E-restricted T cell subset","volume":"24","author":"Moretta","year":"2003","journal-title":"Trends Immunol."},{"key":"10.1016\/j.clim.2009.04.009_bib50","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nri1306","article-title":"Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future","volume":"4","author":"Vivier","year":"2004","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2009.04.009_bib51","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-065X.2008.00651.x","article-title":"Human NK cells: from HLA class I-specific Ig-like receptors to the therapy of acute leukemias","volume":"224","author":"Moretta","year":"2008","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.clim.2009.04.009_bib52","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1471-4906(02)02284-6","article-title":"NK cells: a lesson from mismatched hematopoietic transplantation","volume":"23","author":"Velardi","year":"2002","journal-title":"Trends Immunol."},{"key":"10.1016\/j.clim.2009.04.009_bib53","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1002\/eji.200324533","article-title":"IL21 induces both rapid maturation of human CD34+ cell precursors towards NK cells and acquisition of surface killer Ig-like receptors","volume":"33","author":"Sivori","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2009.04.009_bib54","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4049\/jimmunol.169.1.239","article-title":"Genetic control of human NK cell repertoire","volume":"169","author":"Shilling","year":"2002","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2009.04.009_bib55","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1182\/blood-2002-08-2568","article-title":"Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation","volume":"101","author":"Shilling","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clim.2009.04.009_bib56","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1084\/jem.176.4.963","article-title":"Involvement of HLA class I alleles in NK cell specific function: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2)","volume":"176","author":"Ciccone","year":"1992","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.clim.2009.04.009_bib57","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1002\/eji.1830240434","article-title":"Self Class I molecules protect normal cells from lysis mediated by autologous natural killer cells","volume":"24","author":"Ciccone","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2009.04.009_bib58","doi-asserted-by":"crossref","first-page":"3661","DOI":"10.1182\/blood.V99.10.3661","article-title":"Defective expression and function of natural killer cell triggering receptors in patients with acute myeloid leukemia","volume":"99","author":"Costello","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.clim.2009.04.009_bib59","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.it.2005.02.007","article-title":"Cellular ligands for activating NK receptors","volume":"26","author":"Bottino","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.clim.2009.04.009_bib60","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1182\/blood-2004-09-3548","article-title":"Analysis of the receptor\u2013ligand interactions in the NK-mediated lysis of freshly isolated myeloid or lymphoblastic leukemias. Evidence for the involvement of the poliovirus receptor (CD155) and Nectin-2 (CD112)","volume":"105","author":"Pende","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clim.2009.04.009_bib61","doi-asserted-by":"crossref","first-page":"3948","DOI":"10.1182\/blood.V84.11.3948.bloodjournal84113948","article-title":"Successful engraftment of T-depleted haploidentical \u201cthree-loci\u201d incompatible transplants in leukaemia patients by addition of recombinant human granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells to bone marrow inoculum","volume":"84","author":"Aversa","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.clim.2009.04.009_bib62","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1126\/science.285.5426.412","article-title":"Prevention of graft versus host disease by inactivation of host antigen-presenting cells","volume":"285","author":"Shlomchik","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.clim.2009.04.009_bib63","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1002\/eji.200323986","article-title":"The natural killer cell mediated killing of autologous dendritic cells is confined to a cell subset expressing CD94\/NKG2A, but lacking inhibitory killer IG-like receptors","volume":"33","author":"Della Chiesa","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2009.04.009_bib64","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1182\/blood-2008-06-164103","article-title":"Anti-leukemia activity of alloreactive NK cells in KIR ligand-mismatched haploidentical HSCT for pediatric patients: evaluation of the functional role of activating KIR and re-definition of inhibitory KIR specificity","volume":"113","author":"Pende","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clim.2009.04.009_bib65","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1093\/intimm\/dxh147","article-title":"Isolation of a novel KIR2DL3-specific mAb: comparative analysis of the surface distribution and function of KIR2DL2, KIR2DL3 and KIR2DS2","volume":"16","author":"Vitale","year":"2004","journal-title":"Int. Immunol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166160900655X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166160900655X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,18]],"date-time":"2020-05-18T23:17:14Z","timestamp":1589843834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166160900655X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S152166160900655X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2009.04.009","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}